Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,012
Total Claims
$308K
Drug Cost
303
Beneficiaries
$1,017
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-5%
Cost per patient vs peers
$1,017 vs $1,068 avg
-17%
Brand preference vs peers
7.4% vs 9.0% avg
Brand vs Generic
Brand: 739 claims · $201K
Generic: 9,192 claims · $105K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 52 | $39K |
| Sitagliptin Phos/Metformin Hcl | 33 | $18K |
| Levothyroxine Sodium | 248 | $17K |
| Insulin Glargine,hum.Rec.Anlog | 33 | $16K |
| Linagliptin | 19 | $12K |
| Rivaroxaban | 18 | $11K |
| Levothyroxine Sodium | 712 | $10K |
| Varicella-Zoster Ge/As01b/Pf | 44 | $8,922 |
| Insulin Nph Human Isophane | 44 | $8,736 |
| Insulin Nph Hum/Reg Insulin Hm | 26 | $8,563 |
| Atorvastatin Calcium | 777 | $6,589 |
| Irbesartan/Hydrochlorothiazide | 307 | $6,187 |
| Rivastigmine | 12 | $4,383 |
| Rosuvastatin Calcium | 431 | $3,770 |
| Alendronate Sodium | 558 | $3,655 |
Prescribing Profile
Patient Profile
73
Avg Age
60%
Female
1.41
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data